These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 8183018)
1. [Coronary vessel surgery. Are early operations really superior to the more and more effective drug therapy?]. Ståhle E; Hansson HE; Wallentin L Lakartidningen; 1994 Mar; 91(13):1300-2. PubMed ID: 8183018 [No Abstract] [Full Text] [Related]
2. [Results following coronary revascularization. 478 patients in a detailed follow-up]. Wodlin P; Ahlström P; Holmberg B; Löfström L; Fransson SG; Svedjeholm R; Karlsson E Lakartidningen; 2000 May; 97(20):2452-7. PubMed ID: 10909221 [No Abstract] [Full Text] [Related]
3. Cardiac outcome of major noncardiac surgery in patients undergoing preoperative coronary angioplasty. Jones SE; Raymond RE; Simpfendorfer CC; Whitlow PL J Invasive Cardiol; 1993; 5(6):212-8. PubMed ID: 10172010 [TBL] [Abstract][Full Text] [Related]
4. [Long-term prognosis in patients with single-vessel or double-vessel coronary artery disease: does successful revascularization achieved by coronary angioplasty improve late outcome?]. Kawaharada T J Cardiol; 2003 Jul; 42(1):1-11. PubMed ID: 12892036 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792 [TBL] [Abstract][Full Text] [Related]
6. Is cardiac surgery here to stay in coronary artery disease? de La Fuente LM J Invasive Cardiol; 2001 May; 13(5):419-21. PubMed ID: 11385161 [No Abstract] [Full Text] [Related]
7. "Hybrid" and combined percutaneous and surgical intervention to treat selected cardiac patients: a new strategy. Presbitero P; Gallotti R; Belli G; Franciosi G; Maiello L; Nicolini F; Manasse E; Citterio E; Carcagnì A; Foresti A G Ital Cardiol; 1999 Jan; 29(1):27-33. PubMed ID: 9987044 [TBL] [Abstract][Full Text] [Related]
8. [Indications for coronary dilatation and bypass surgery]. Meier B Schweiz Med Wochenschr; 1993 Feb; 123(7):301-10. PubMed ID: 8446866 [TBL] [Abstract][Full Text] [Related]
9. [Percutaneous transluminal coronary angioplasty]. Sousa JE; Büchler JR; Pimentel Filho WA; de Moraes AG Arq Bras Cardiol; 1980 Jul; 35(1):1-4. PubMed ID: 7224884 [No Abstract] [Full Text] [Related]
10. Choosing a revascularization strategy for your patient with CAD. Consider both the clinical presentation and the urgency of the situation. Aranki SF; Cohn LH J Crit Illn; 1995 Sep; 10(9):591-6. PubMed ID: 10155165 [TBL] [Abstract][Full Text] [Related]
11. Safety of elective--including "high risk"--percutaneous coronary interventions without on-site cardiac surgery. Zavala-Alarcon E; Cecena F; Ashar R; Patel R; Van Poppel S; Carlson R Am Heart J; 2004 Oct; 148(4):676-83. PubMed ID: 15459600 [TBL] [Abstract][Full Text] [Related]
12. Today's approach to PTCA: how it is performed, who might benefit. When can angioplasty replace medical therapy or bypass surgery? Moscucci M; Feldman T J Crit Illn; 1993 Feb; 8(2):185-8; 191-3; 197-208. PubMed ID: 10148331 [TBL] [Abstract][Full Text] [Related]
13. PCI for stable coronary disease. Kiat H N Engl J Med; 2007 Jul; 357(4):416; author reply 417-8. PubMed ID: 17663026 [No Abstract] [Full Text] [Related]
14. [Coronary restenosis. An unresolved problem of percutaneous transluminal coronary angioplasty]. Iñíguez Romo A Rev Esp Cardiol; 1993; 46 Suppl 3():85-96. PubMed ID: 8303057 [No Abstract] [Full Text] [Related]
15. PTCA with the use of cardiac assist devices: risk stratification, short- and long-term results. Ferrari M; Scholz KH; Figulla HR Cathet Cardiovasc Diagn; 1996 Jul; 38(3):242-8. PubMed ID: 8804779 [TBL] [Abstract][Full Text] [Related]
16. [Transluminal coronary angioplasty performed in patients with single vessel disease of the right coronary artery disease. Long-term results]. Abrysch F; Finet G; Roriz R; Durnad de Gevigney G; Rioufol G; André-Fouet X; Ovize M; Beaune J Arch Mal Coeur Vaiss; 2000 Jan; 93(1):27-33. PubMed ID: 11227715 [TBL] [Abstract][Full Text] [Related]
17. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321 [TBL] [Abstract][Full Text] [Related]
18. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Kappetein AP; Dawkins KD; Mohr FW; Morice MC; Mack MJ; Russell ME; Pomar J; Serruys PW Eur J Cardiothorac Surg; 2006 Apr; 29(4):486-91. PubMed ID: 16497510 [TBL] [Abstract][Full Text] [Related]
19. Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve disease. Byrne JG; Leacche M; Unic D; Rawn JD; Simon DI; Rogers CD; Cohn LH J Am Coll Cardiol; 2005 Jan; 45(1):14-8. PubMed ID: 15629366 [TBL] [Abstract][Full Text] [Related]
20. Surgery or percutaneous coronary intervention for three-vessel and left main coronary artery disease: a critical appraisal of the literature. Alison P; Sidebotham D N Z Med J; 2007 Jun; 120(1255):U2557. PubMed ID: 17546105 [No Abstract] [Full Text] [Related] [Next] [New Search]